Title | Type | SJR | H index | Total Docs. (2000) | Total Docs. (3years) | Total Refs. (2000) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2000) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
51 | Journal of Neuro-Oncology | journal | 0.652 Q2 | 135 | 141 | 481 | 6186 | 865 | 471 | 1.59 | 43.87 | |
52 | Oncology | journal | 0.650 Q2 | 107 | 112 | 320 | 3363 | 537 | 310 | 1.53 | 30.03 | |
53 | Nuclear Medicine and Biology | journal | 0.641 Q2 | 98 | 123 | 360 | 3549 | 632 | 357 | 1.80 | 28.85 | |
54 | Tumor Biology | journal | 0.636 Q2 | 101 | 41 | 173 | 1168 | 265 | 172 | 1.38 | 28.49 | |
55 | Journal of Cancer Research and Clinical Oncology | journal | 0.630 Q2 | 109 | 108 | 328 | 3833 | 545 | 312 | 1.68 | 35.49 | |
56 | Progress in Experimental Tumor Research | book series | 0.626 Q2 | 20 | 0 | 25 | 0 | 29 | 25 | 1.16 | 0.00 | |
57 | Cancer Letters | journal | 0.622 Q2 | 216 | 396 | 1194 | 11164 | 2143 | 1191 | 1.63 | 28.19 | |
58 | Cancer Investigation | journal | 0.621 Q2 | 93 | 106 | 275 | 4424 | 363 | 237 | 1.22 | 41.74 | |
59 | Cancer Genetics and Cytogenetics | journal | 0.617 Q2 | 78 | 268 | 778 | 6222 | 1232 | 709 | 1.40 | 23.22 | |
60 | Anti-Cancer Drugs | journal | 0.606 Q2 | 102 | 121 | 399 | 3792 | 669 | 396 | 1.58 | 31.34 | |
61 | Oral Oncology | journal | 0.606 Q2 | 137 | 91 | 228 | 2907 | 380 | 213 | 1.58 | 31.95 | |
62 | Apoptosis : an international journal on programmed cell death | journal | 0.577 Q2 | 128 | 62 | 148 | 3054 | 189 | 148 | 0.92 | 49.26 | |
63 | Lung Cancer | journal | 0.576 Q2 | 148 | 107 | 250 | 2911 | 392 | 238 | 1.49 | 27.21 | |
64 | Journal of Oral Pathology and Medicine | journal | 0.542 Q2 | 95 | 74 | 266 | 2398 | 416 | 265 | 1.45 | 32.41 | |
65 | Anticancer Research | journal | 0.541 Q2 | 136 | 832 | 2402 | 23223 | 3683 | 2398 | 1.38 | 27.91 | |
66 | European Journal of Cancer Prevention | journal | 0.529 Q3 | 88 | 70 | 281 | 2111 | 415 | 256 | 1.45 | 30.16 | |
67 | Leukemia and Lymphoma | journal | 0.522 Q3 | 102 | 296 | 881 | 11002 | 1287 | 869 | 1.32 | 37.17 | |
68 | Leukemia Research | journal | 0.514 Q3 | 96 | 140 | 469 | 4371 | 647 | 424 | 1.39 | 31.22 | |
69 | Angiogenesis | journal | 0.479 Q3 | 101 | 0 | 88 | 0 | 84 | 88 | 0.79 | 0.00 | |
70 | Cancer Epidemiology | journal | 0.471 Q3 | 86 | 71 | 205 | 2491 | 284 | 204 | 1.37 | 35.08 | |
71 | Endocrine-Related Cancer | journal | 0.470 Q3 | 146 | 19 | 142 | 2341 | 177 | 137 | 1.57 | 123.21 | |
72 | Molecular Imaging and Biology | journal | 0.470 Q3 | 78 | 72 | 60 | 498 | 47 | 60 | 0.78 | 6.92 | |
73 | European Journal of Cancer Part B: Oral Oncology | journal | 0.463 Q3 | 37 | 0 | 51 | 0 | 75 | 51 | 0.00 | 0.00 | |
74 | Experimental Hematology | journal | 0.450 Q3 | 129 | 158 | 1581 | 6804 | 1435 | 1557 | 1.26 | 43.06 | |
75 | Journal of Brachytherapy International | journal | 0.448 Q3 | 12 | 29 | 92 | 589 | 56 | 92 | 0.64 | 20.31 | |
76 | Prostate Cancer and Prostatic Diseases | journal | 0.443 Q3 | 78 | 96 | 175 | 1950 | 98 | 154 | 0.56 | 20.31 | |
77 | Neuro-Oncology | journal | 0.438 Q3 | 163 | 29 | 29 | 830 | 40 | 29 | 1.38 | 28.62 | |
78 | American Journal of Clinical Oncology: Cancer Clinical Trials | journal | 0.436 Q3 | 90 | 138 | 414 | 2903 | 498 | 404 | 1.09 | 21.04 | |
79 | Oncology | journal | 0.422 Q3 | 83 | 318 | 958 | 2399 | 909 | 903 | 0.98 | 7.54 | |
80 | Oncology Reports | journal | 0.417 Q3 | 115 | 236 | 800 | 3665 | 842 | 799 | 1.41 | 15.53 | |
81 | Medical Oncology | journal | 0.416 Q3 | 90 | 58 | 126 | 1896 | 161 | 121 | 1.28 | 32.69 | |
82 | Journal of Biological Regulators and Homeostatic Agents | journal | 0.415 Q3 | 56 | 53 | 95 | 1189 | 104 | 93 | 0.81 | 22.43 | |
83 | International Journal of Biological Markers | journal | 0.409 Q3 | 47 | 56 | 122 | 1314 | 116 | 99 | 1.03 | 23.46 | |
84 | Tumor Targeting | journal | 0.404 Q3 | 10 | 0 | 54 | 0 | 56 | 52 | 1.04 | 0.00 | |
85 | Japanese Journal of Clinical Oncology | journal | 0.400 Q3 | 95 | 139 | 417 | 1949 | 341 | 365 | 0.71 | 14.02 | |
86 | Oncologist | journal | 0.390 Q3 | 189 | 94 | 203 | 3283 | 157 | 173 | 0.98 | 34.93 | |
87 | Pathology and Oncology Research | journal | 0.368 Q3 | 61 | 49 | 99 | 823 | 81 | 99 | 0.82 | 16.80 | |
88 | In Vivo | journal | 0.364 | 72 | 110 | 260 | 5450 | 283 | 260 | 0.94 | 49.55 | |
89 | Hematological Oncology | journal | 0.356 Q3 | 54 | 16 | 53 | 533 | 56 | 53 | 0.65 | 33.31 | |
90 | Human Cell | journal | 0.354 Q3 | 44 | 27 | 83 | 313 | 54 | 81 | 0.52 | 11.59 | |
91 | Pathogenesis | journal | 0.352 Q3 | 8 | 7 | 6 | 364 | 4 | 6 | 0.67 | 52.00 | |
92 | Cancer Biotherapy and Radiopharmaceuticals | journal | 0.313 Q3 | 68 | 66 | 159 | 2110 | 157 | 141 | 0.88 | 31.97 | |
93 | Cancer Treatment and Research | journal | 0.290 Q3 | 65 | 19 | 200 | 588 | 116 | 200 | 0.50 | 30.95 | |
94 | Environmental Carcinogenesis and Ecotoxicology Reviews | journal | 0.267 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
95 | Breast | journal | 0.264 | 98 | 74 | 225 | 1695 | 113 | 213 | 0.49 | 22.91 | |
96 | Journal of Experimental and Clinical Cancer Research | journal | 0.257 Q3 | 120 | 83 | 255 | 2323 | 172 | 248 | 0.62 | 27.99 | |
97 | Tumori | journal | 0.243 Q3 | 59 | 180 | 472 | 3538 | 277 | 466 | 0.54 | 19.66 | |
98 | Neoplasma | journal | 0.235 Q3 | 57 | 73 | 248 | 1887 | 161 | 247 | 0.62 | 25.85 | |
99 | Brain Tumor Pathology | journal | 0.223 Q3 | 45 | 23 | 58 | 252 | 27 | 57 | 0.41 | 10.96 | |
100 | Cancer Journal | journal | 0.202 Q4 | 16 | 0 | 102 | 0 | 60 | 92 | 0.51 | 0.00 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®